An Open Label study to examine the effects of DAS 181 administered by Dry Powder Inhaler (DPI) or Nebulized formulation in Immunocompromised subjects with Parainfluenza (PIV) Infection
Clinical Trial Grant
Administered By
Medicine, Infectious Diseases
Awarded By
Ansun BioPharma,Inc
Start Date
November 1, 2013
End Date
October 31, 2016
Administered By
Medicine, Infectious Diseases
Awarded By
Ansun BioPharma,Inc
Start Date
November 1, 2013
End Date
October 31, 2016